Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Human scalp hair follicles have PGE2 and its receptors, which might affect hair growth.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Different types of cells in the eye express specific keratins at various stages of development.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Alopecia areata can be managed with various treatments, and severe cases should be referred to dermatologists.

Low-dose oral minoxidil can improve hair and eyebrow growth in frontal fibrosing alopecia.

Hair thickness decreases from the upper to lower areas of the back of the head, affecting hair transplant results.

Finasteride was more effective than hydroxychloroquine in treating frontal fibrosing alopecia.

Follicular Unit Extraction (FUE) is a popular hair transplant method with minimal scarring that can transplant many grafts quickly and improve appearance and psychological well-being.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

Latanoprost and minoxidil effectively control hair loss and increase hair count.

Current treatments for alopecia areata often fail to achieve and maintain significant hair regrowth.

Hair loss can cause emotional and social issues, and various treatments, including medication, surgery, and psychological support, are needed.

HIV can cause various nail and hair disorders, important for early diagnosis and treatment.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

The study found that Frontal Fibrosing Alopecia in North-East India mainly affects middle-aged women and is often associated with lichen planus pigmentosus.

A person was born with both a rare hairless condition and a type of birthmark, which is an uncommon combination.

A man with lung cancer had skin and eye side effects from erlotinib but continued treatment with symptom improvement.

Hair transplantation is a surgical procedure to move hair to bald areas, requires good donor hair, and results show in about a year.

Cyclosporine may cause hair loss, so patients need monitoring.

A 12-year-old boy with a rare genetic condition has progressive hair loss with no effective treatment.

Fractional laser treatment helped hair regrowth in patients with alopecia areata.

A man had an unusual type of hair loss that didn't match known patterns and didn't improve with treatment.

Hair loss condition FFA was seen before the appearance of skin depigmentation vitiligo in a patient.

A 47-year-old man's eyelid swelling didn't improve with basic treatments, so a biopsy was needed.

A new mutation in the CDH3 gene causes hair loss and vision problems in a young girl.